• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    BeautyHealth Strengthens Commercial Leadership to Accelerate International Expansion, Naming Regional Presidents for EMEA, Southeast Asia

    8/29/22 8:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care
    Get the next $SKIN alert in real time by email

    Beauty industry vet Jon Arnold returns to EMEA to lead growth acceleration

    Stefanie Gebauer brings skin and hair expertise to drive critical SEA development

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today strengthened its commercial leadership with the appointment of Jon Arnold as President, EMEA, and Stefanie Gebauer as President, Southeast Asia. The two leaders will join BeautyHealth's Executive Committee and drive end-to-end commercial operations in their respective regions, overseeing in-market teams, the local P&L, go-to-market strategy, marketing and sales.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220829005232/en/

    Stefanie Gebauer, President, Southeast Asia, BeautyHealth (Photo: Business Wire)

    Stefanie Gebauer, President, Southeast Asia, BeautyHealth (Photo: Business Wire)

    The appointments are part of an ambitious Master Plan for BeautyHealth, as the company accelerates to capture share in the booming global beauty-health market—a large and growing space at the intersection of beauty, aesthetics, health and wellness. These categories are ripe for disruption through the application of superior beauty technology, which BeautyHealth is known for from its category-creating Hydrafacial platform.

    Jon and Stefanie assume responsibility for increasing Hydrafacial's omnichannel penetration within medical, spa, retail and hospitality locations; and fostering the growth of the Hydrafacial Nation, a global community of provider and consumer "skinthusiasts" dedicated to the brand. As part of this, they will lead the planned rollout of Hydrafacial's next generation delivery system, Syndeo, in EMEA and APAC in 2023.

    "I am thrilled to have Jon and Stefanie come aboard. They round out a global commercial team that has delivered record results in recent quarters and stand to boost BeautyHealth's performance in some of our most important growth regions," said BeautyHealth President and CEO Andrew Stanleick.

    A longtime commercial leader, Jon has built teams and strategies to drive growth and turnaround for consumer product businesses around the world. Most recently he served as Chief Commercial Officer for the Americas at French spirits group Rémy Cointreau. Prior, he spent more than 20 years at beauty conglomerate L'Oréal, including as General Manager for the Australia Consumer Products division, where he led a strategic return of the group to profitability.

    "Jon is a beauty industry veteran, who has delivered transformational growth time and again, making him well suited to lead our EMEA business, where the opportunity for expansion and penetration is enormous. He is a collaborative and visionary leader, who no doubt will inspire our EMEA team to new heights," added Andrew.

    "I am delighted to join Andrew and the rest of the BeautyHealth team as it embarks on its next growth chapter. Personally, I am very excited and honored to lead the EMEA Team," said Jon. "Hydrafacial's unique technologies and category-disrupting mindset are incredibly exciting, and there is a huge opportunity to deliver our great products and innovations to address the beauty needs of millions more consumers across the continent."

    Stefanie is a Southeast Asia beauty expert, leading luxury skin and hair care brands in the region over the past two decades. She drove the in-region business for Shiseido Prestige brands, John Master Organics, Aesop and L'Oréal, and advised consumer products and retail clients at Monitor Deloitte and Kearney.

    "Stefanie, as our lead for Southeast Asia, brings a deep background of APAC brand marketing and beauty experience. She is quick, precise and deeply in tuned with the most important market trends. She will add a critical perspective to our overall business and lead our next phase of explosive growth," said Andrew.

    "I am excited to join BeautyHealth to expand and drive the business and brand awareness in the Southeast Asia region. I look forward to working with Andrew and the team at BeautyHealth to create value and growth across new markets, accelerating the global presence for the company," said Stefanie.

    BeautyHealth has recently taken a more focused approach in APAC, splitting the regional leadership in two—North Asia and Southeast Asia—with a dedicated President and teams in each of the sub-regions. This bifurcated focus allows teams on the ground to better respond to the unique needs of each country and truly harness the potential of APAC.

    Med-Tech industry veteran, Mingo Ku continues to lead the North Asia region where he has been delivering excellent results despite the China Covid lock-downs. He is focused on building up the sales and marketing infrastructure in the region to position BeautyHealth for rapid expansion.

    About The Beauty Health Company

    The Beauty Health Company (NASDAQ:SKIN) is a global category-creating company delivering beauty health experiences that help consumers reinvent their relationship with their skin, bodies and self-confidence. Our flagship brand, Hydrafacial™, created the category of hydradermabrasion by using a patented vortex-fusion delivery system to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Hydrafacial provides a non-invasive and approachable skincare experience. Together, with our powerful community of aestheticians, consumers and partners, we are personalizing skincare solutions for all ages, genders, skin tones, and skin types. Hydrafacial is available in more than 90 countries with an install base of nearly 23,000 delivery systems providing millions of experiences to consumers each year. Find a local Hydrafacial at https://Hydrafacial.com/find-a-provider/. For more information, visit www.beautyhealth.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220829005232/en/

    Get the next $SKIN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SKIN

    DatePrice TargetRatingAnalyst
    11/15/2023$11.00 → $1.50Buy → Hold
    Jefferies
    11/14/2023$10.00 → $2.50Buy → Hold
    Canaccord Genuity
    11/14/2023Neutral → Underweight
    JP Morgan
    11/14/2023$12.00 → $2.00Overweight → Underweight
    Piper Sandler
    11/14/2023$9.00 → $2.50Outperform → Market Perform
    TD Cowen
    11/14/2023Buy → Hold
    The Benchmark Company
    11/14/2023Mkt Perform → Underperform
    Raymond James
    11/14/2023Outperform → Mkt Perform
    William Blair
    More analyst ratings

    $SKIN
    Financials

    Live finance-specific insights

    See more
    • BeautyHealth Reports First Quarter 2025 Financial Results

      LONG BEACH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2025 ("Q1 2025"). "Our first quarter results reflect strong execution and continued momentum in our transformation strategy," said CEO Marla Beck. "We exceeded both revenue and adjusted EBITDA guidance, driven by gross profit growth and meaningful cost efficiencies. Despite macroeconomic pressures that impacted device sales, consumables revenue remained resilient, reinforcing the strength of our recurring revenue model and sustained consumer dem

      5/8/25 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth to Report First Quarter 2025 Financial Results on May 8, 2025

      LONG BEACH, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report first quarter 2025 financial results after market close on Thursday, May 8, 2025. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure InformationThe Beauty Health Company announces m

      4/29/25 4:00:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results

      LONG BEACH, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the fourth quarter ended December 31, 2024 ("Q4 2024"). "In Q4 2024, we continued to strengthen our financial position, exceeding the high end of our guidance for both net sales and adjusted EBITDA," said CEO Marla Beck. "We increased consumable sales, expanded our gross margins and continued to reduce our operating expenses, delivering $9 million of adjusted EBITDA in the quarter. We now have over 34,000 global delivery systems serving our large provider base." "In 2025, we are focused on deepening

      3/12/25 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Leadership Updates

    Live Leadership Updates

    See more
    • The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of two accomplished industry executives to its commercial leadership team. Ron Menezes will join Beauty Health as Chief Revenue Officer and Carrie Caulkins will join the Company as Chief Marketing Officer, effective October 15, 2024, with both reporting to the Company's Chief Executive Officer, Marla Beck. Mr. Menezes assumes his new role from Dan ("Doc") Watson, who is leaving Beauty Health and will assist with the transition through year-end. Ms. Caulkins fills an open position. Marla Beck commented on the appointments, "We are thrilled to welcome Ron and Carrie to the executive t

      10/15/24 4:10:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately. Ms. Lewis will report to BeautyHealth's President and Chief Executive Officer, Marla Beck. "Sheri is a talented and deeply experienced executive who brings decades of valuable global operations expertise to BeautyHealth as we chart the future of the Company," said Marla Beck, BeautyHealth President and Chief Executive Officer. "The Board of Directors and I are confident that her deep industry experience across global supply chain and operations will play a critical role in advancing our strategic

      4/9/24 4:10:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has unanimously approved Marla Beck as the Company's permanent President and Chief Executive Officer. Ms. Beck has been Interim CEO since November 20, 2023, in addition to serving on the Company's Board of Directors, which she will continue to do going forward. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312423257/en/SKIN) (Photo: Business Wire)">Marla Beck, President and Chief Executive Officer, The Beauty Health Company (NASDAQ:SKIN) (Photo: Business Wire) "Over the past few months, the Board has undertaken

      3/12/24 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BeautyHealth Surpasses 35,000 Hydrafacial Devices Worldwide Reflecting Growing Consumer Demand for Clinically Proven Skin Health Treatments

      LONG BEACH, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, recently achieved a major milestone with 35,000 Hydrafacial devices installed worldwide, reinforcing its market leadership in the hydradermabrasion category it pioneered. This accomplishment highlights the Hydrafacial treatment's continued global demand, fueled by strong brand awareness, and growing consumer preferences for non-invasive, results-driven skin health treatments. "With providers delivering approximately 5 million Hydrafacial treatments last year1, our position as one of the most in-demand professional skin health treatments is clear," said Beaut

      6/4/25 8:00:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company Announces Convertible Debt Refinancing

      LONG BEACH, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced that it entered into privately negotiated exchange agreements (the "Exchange Agreements") with certain holders (the "Exchanging Holders") of the Company's outstanding 1.25% convertible senior notes due 2026 (the "Existing Notes"). "Our refinancing marks a critical step in strengthening our financial position and extending a portion of our debt maturity, giving us greater flexibility to invest in long-term, profitable growth," said BeautyHealth Chief Executive Officer Marla Beck. "With a robust pipeline of innovation and bold brand initiatives,

      5/21/25 8:00:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Reports First Quarter 2025 Financial Results

      LONG BEACH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2025 ("Q1 2025"). "Our first quarter results reflect strong execution and continued momentum in our transformation strategy," said CEO Marla Beck. "We exceeded both revenue and adjusted EBITDA guidance, driven by gross profit growth and meaningful cost efficiencies. Despite macroeconomic pressures that impacted device sales, consumables revenue remained resilient, reinforcing the strength of our recurring revenue model and sustained consumer dem

      5/8/25 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 4:16:27 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 11:27:23 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 11:03:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      8/13/24 5:00:11 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Monahan Michael P. covered exercise/tax liability with 24,290 shares, decreasing direct ownership by 2% to 1,358,662 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      6/3/25 4:10:01 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • CSO and COO Lewis Sheri covered exercise/tax liability with 31,296 shares, decreasing direct ownership by 3% to 914,726 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      4/11/25 4:46:48 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • President and CEO Beck Marla Malcolm covered exercise/tax liability with 92,981 shares, decreasing direct ownership by 3% to 2,753,401 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      4/11/25 4:44:21 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    SEC Filings

    See more
    • The Beauty Health Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - Beauty Health Co (0001818093) (Filer)

      5/27/25 5:19:53 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Beauty Health Co (0001818093) (Filer)

      5/21/25 4:13:53 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by The Beauty Health Company

      SCHEDULE 13G/A - Beauty Health Co (0001818093) (Subject)

      5/14/25 12:01:27 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • The Beauty Health Company downgraded by Jefferies with a new price target

      Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously

      11/15/23 7:13:27 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company downgraded by JP Morgan

      JP Morgan downgraded The Beauty Health Company from Neutral to Underweight

      11/14/23 7:45:38 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company downgraded by Canaccord Genuity with a new price target

      Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously

      11/14/23 7:45:38 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care